Heptares
discovers and develops new medicines targeting GPCRs... Read moreHeptares
discovers and develops new medicines targeting GPCRs... Read more
News
Feb 04, 2019
BioCentury
Heptares: Heptares, Medicxi spin out narcolepsy newcos
Nov 10, 2018
BioPortfolio
Heptares: Heptares Therapeutics Ltd Pharmaceuticals Healthcare Deals and Alliances Profile Report Updated 07092018 Prices from USD $250
Nov 07, 2018
The Pharma Letter
Heptares: BRIEF-Sosei signs R&D deal with DyNAbind
Oct 19, 2018
Cambridge Independent
Heptares: It's a new day for Sosei Heptares
Sep 08, 2018
BioPortfolio
Heptares: Heptares Therapeutics Ltd Pharmaceuticals Healthcare Deals and Alliances Profile Report Updated 17042018 Prices from USD $250
Mar 19, 2018
BioPortfolio
Heptares: Heptares Therapeutics Ltd Pharmaceuticals Healthcare Deals and Alliances Profile Report Updated 12032018 Prices from USD $250
Jan 22, 2018
BioSpace
Heptares: Hepatares Co-Founder to Helm Merck's New R&D Center in the UK
Jan 19, 2018
BioSpace
Heptares: Heptares Co-Founder Resigns as VP and CSO of Parent Company Sosei
Jan 12, 2018
Pharamceutical Technology
Heptares: Japan's Heptares joins Imperial College London for drug R&D
Jan 11, 2018
PharmaTimes
Heptares: Heptares, ICL sign gastrointestinal R&D pact
Heptares Competitors
1
2
3
4
5
6
7
8
9
10